Eli Lilly and Company Lilly's triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trial
Why This Matters for Side Effects Gastrointestinal side effects such as nausea, vomiting, and diarrhea are common with both oral and injectable GLP-1 medications, occurring at rates similar across formulations and generally described as mild to moderate. Starting at lower doses and titrating carefully, as Whoosh's protocols are designed to do, is one of the most effective ways to minimize these effects while still achieving meaningful weight loss
Quick Answer: Most people notice appetite suppression within days to two weeks of starting GLP-1 treatment, blood glucose improvements within 24 weeks, and meaningful weight loss over 36 months
J Pediatr Gastroenterol Nutr
Many of these industrial chemicals are the basic ingredients in our cosmetics and personal care products
Meet Amy Women's health researcher, science writer, and GLP-1 patient